Version June 2024
| Author, year | Regimen | Progression-free/total (percent) |
| Adjuvant chemotherapy | ||
| Williams, SD; 1994 | BEP | 89/93 (96) |
| Segelov, E; 1994 | Multiple | 9/10 (90) |
| Rogers, P; 2004 | BEP | 70/74 (95) |
| Gershenson, D; 1986 | PVB | 4/4 (100) |
| Culine, S; 1997 | Cisplatin-based | 23/24 (96) |
| Bafna, UD; 2001 | BEP | 14/16 (88) |
| Gershenson, D; 1990 | BEP | 20/20 (100) |
| Lai, CH; 2005 | Multiple | 66/67 (99) |
| Dimopoulos, MA; 1998 | BEP, PVB | 17/19 (89) |
| Advanced disease | ||
| Williams, SD; 1989 | PVB | 47/89 (53) |
| Segelov, E; 1994 | Multiple | 42/46 (91) |
| Gershenson, D; 1986 | PVB | 7/11 (64) |
| Culine, S; 1997 | Cisplatin-based | 17/30 (57) |
| Pawinski, A; 1998 | PVB | 12/18 (67) |
| Bafna, UD; 2001 | BEP | 3/6 (50) |
| Gershenson, D; 1990 | BEP | 5/6 (83) |
| Dimopoulos, MA; 1998 | BEP, PVB | 17/21 (80) |
| Lai, CH; 2005 | Multiple | 15/19 (79) |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
